Vascular Injury After Stenting - Insights of Systemic Mechanisms of Vascular Repair.


Journal

Circulation journal : official journal of the Japanese Circulation Society
ISSN: 1347-4820
Titre abrégé: Circ J
Pays: Japan
ID NLM: 101137683

Informations de publication

Date de publication:
25 05 2022
Historique:
pubmed: 3 12 2021
medline: 28 5 2022
entrez: 2 12 2021
Statut: ppublish

Résumé

The role of circulating progenitor cells (CPC) in vascular repair following everolimus-eluting stent (EES) implantation is largely unknown. The aim of the study was to investigate the relationship between temporal variation in CPC levels following EES implantation and the degree of peri-procedural vascular damage, and stent healing, as measured by optical coherence tomography (OCT).Methods and Results: CPC populations (CD133+/KDR+/CD45low) included patients with stable coronary artery disease undergoing stent implantation, and were evaluated using a flow cytometry technique both at baseline and at 1 week. OCT evaluation was performed immediately post-implantation to quantify the stent-related injury and at a 9-month follow up to assess the mid-term vascular response. Twenty patients (mean age 66±9 years; 80% male) with EES-treated stenoses (n=24) were included in this study. Vascular injury score was associated with the 1-week increase of CD133+/KDR+/CD45low (β 0.28 [95% CI 0.15; 0.41]; P<0.001) and with maximum neointimal thickness at a 9-month follow up (β 0.008 [95% CI 0.0004; 0.002]; P=0.04). Inverse relationships between numbers of uncoated and apposed struts for the 9-month and the 1-week delta values of CD133+/KDR+/CD45low (β -12.53 [95% CI -22.17; -2.90]; P=0.011), were also found. The extent of vessel wall injury influences early changes in the levels of CPC and had an effect on mid-term vascular healing after EES implantation. Early CPC mobilisation was associated with mid-term strut coverage.

Sections du résumé

BACKGROUND
The role of circulating progenitor cells (CPC) in vascular repair following everolimus-eluting stent (EES) implantation is largely unknown. The aim of the study was to investigate the relationship between temporal variation in CPC levels following EES implantation and the degree of peri-procedural vascular damage, and stent healing, as measured by optical coherence tomography (OCT).Methods and Results: CPC populations (CD133+/KDR+/CD45low) included patients with stable coronary artery disease undergoing stent implantation, and were evaluated using a flow cytometry technique both at baseline and at 1 week. OCT evaluation was performed immediately post-implantation to quantify the stent-related injury and at a 9-month follow up to assess the mid-term vascular response. Twenty patients (mean age 66±9 years; 80% male) with EES-treated stenoses (n=24) were included in this study. Vascular injury score was associated with the 1-week increase of CD133+/KDR+/CD45low (β 0.28 [95% CI 0.15; 0.41]; P<0.001) and with maximum neointimal thickness at a 9-month follow up (β 0.008 [95% CI 0.0004; 0.002]; P=0.04). Inverse relationships between numbers of uncoated and apposed struts for the 9-month and the 1-week delta values of CD133+/KDR+/CD45low (β -12.53 [95% CI -22.17; -2.90]; P=0.011), were also found.
CONCLUSIONS
The extent of vessel wall injury influences early changes in the levels of CPC and had an effect on mid-term vascular healing after EES implantation. Early CPC mobilisation was associated with mid-term strut coverage.

Identifiants

pubmed: 34853277
doi: 10.1253/circj.CJ-21-0649
doi:

Substances chimiques

Everolimus 9HW64Q8G6G
Sirolimus W36ZG6FT64

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

966-974

Commentaires et corrections

Type : CommentIn

Auteurs

Pilar Jimenez-Quevedo (P)

Clinico San Carlos University Hospital, IdISSC.

Esther Bernardo (E)

Clinico San Carlos University Hospital, IdISSC.

Maria Del Trigo (M)

Clinico San Carlos University Hospital, IdISSC.

Shuji Otsuki (S)

University Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS).

Luis Nombela-Franco (L)

Clinico San Carlos University Hospital, IdISSC.

Salvatore Brugaletta (S)

University Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS).

Arancha Ortega-Pozi (A)

Clinico San Carlos University Hospital, IdISSC.

Raul Herrera (R)

Clinico San Carlos University Hospital, IdISSC.

Pablo Salinas (P)

Clinico San Carlos University Hospital, IdISSC.

Ivan Nuñez-Gil (I)

Clinico San Carlos University Hospital, IdISSC.

Hernan Mejía-Rentería (H)

Clinico San Carlos University Hospital, IdISSC.

Fernando Alfonso (F)

Clinico San Carlos University Hospital, IdISSC.

Cristina Fernandez-Perez (C)

Clinico San Carlos University Hospital, IdISSC.

Antonio Fernandez-Ortiz (A)

Clinico San Carlos University Hospital, IdISSC.

Carlos Macaya (C)

Clinico San Carlos University Hospital, IdISSC.

Javier Escaned (J)

Clinico San Carlos University Hospital, IdISSC.

Manel Sabate (M)

University Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS).

Nieves Gonzalo (N)

Clinico San Carlos University Hospital, IdISSC.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH